Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PHARMX TECHNOLOGIES LIMITED Declaration of Voting Results & Voting Rights Announcements 2017

Nov 28, 2017

65560_rns_2017-11-28_d2baf2d4-4565-4bee-b072-0d5381575394.pdf

Declaration of Voting Results & Voting Rights Announcements

Open in viewer

Opens in your device viewer

==> picture [119 x 60] intentionally omitted <==

Market Release

29 November 2017

Results of Annual General Meeting held on 29 November 2017

In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act, Corum Group Limited advises the results of voting and the proxies received in respect of each resolution at the Annual General Meeting held today.

1. Adopt the Remuneration Report

The instructions given to validly appointed proxies in respect of the resolution were as follows:

For Against Abstain Proxy's discretion
12,866,032 2,899,356 40,538 16,860,057

The motion did not pass as an ordinary resolution on a poll, the details of which are:

For Against Abstain
13,092,53223.7% 42,223,54176.3% 185,957

2. Re-election of Bill Paterson as a Director

The instructions given to validly appointed proxies in respect of the resolution were as follows:

For Against Abstain Proxy's discretion
153,501,159 2,269,915 20,079 16,928,209

The motion was carried as an ordinary resolution on a show of hands.

David Clarke Company Secretary

Corum Group Limited | ABN 25 000 091 305 Level 20, 347 Kent Street, Sydney NSW 2000 PO Box Q281, Queen Victoria Building NSW 1230 T 02 9289 4699 | F 02 9299 3276 | www.corumgroup.com.au